Results 171 to 180 of about 31,450 (226)

Circadian nutrition meets intermittent hypoxia: a timely fix for dysglycemia? [PDF]

Sleep
Masury H, Fradkov S, Gileles-Hillel A.
europepmc   +1 more source

Expression analysis and possible functional roles of semaphorin/plexin/CRMP families in mouse pancreatic islets. [PDF]

Sci Rep
Kyohara M, Takayanagi R, Tsuno T, Ong Yajima E, Inoue R, Yamashita N, Okuyama T, Nishiyama K, Matsunaga K, Ishida E, Ito S, Terauchi Y, Goshima Y, Shirakawa J.   +13 more
europepmc   +1 more source

Randomized Double-blind Placebo-controlled study to evaluate the efficacy of fermented deglycyrrhizinated licorice for treatment of diabetic polyneuropathy. [PDF]

Endocrine
Massoud AMA, Massoud HMA, El-Shawarby AA, Elseidy MI.   +3 more
europepmc   +1 more source

Network Pharmacology-Based Elucidation of the Hypoglycemic Mechanism of <i>Grifola frondosa</i> GF5000 Polysaccharides via GCK modulation in Diabetic Rats. [PDF]

Nutrients
Xiao C, Jiao C, Huang L, Hu H, Xie Y, Wu Q.   +5 more
europepmc   +1 more source

Editorial: NAFLD treatment in diabetes: from current dietary interventions to novel treatment. [PDF]

Front Endocrinol (Lausanne)
Nevola R, Costabile G, Della Pepa G.
europepmc   +1 more source

NAFLD-related SNPs are linked to changes in liver fat, as measured by the CAP score, and serum lipids in response to a 3-week sugar-sweetened beverage intervention: a pilot study.

Food Funct
Jeyaraj FT, Vennam SS, Nelson K, Watts K, Goss LR, Nance BC, Mass BB, Voruganti VS.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Glucokinase Activators

Pharmaceutical Patent Analyst, 2012
In this review we highlight recently disclosed progress in the field of small-molecule activators of the human glucokinase enzyme. Several of the reported chemotypes possess structural features that diverge from known leads; some of these modifications appear to be specifically designed to modulate tissue selectivity or discrete parameters of enzyme ...
Kevin J, Filipski, Kentaro, Futatsugi, Jeffrey A, Pfefferkorn, Benjamin D, Stevens   +3 more
openaire   +4 more sources

Glucokinase-defective NIDDM

Lancet, The, 1993
Hideki Katagiri, Tomoichiro Asano, Toshikazu Yamanouchi, Yoshio Yazaki, Yoshitomo Oka   +4 more
exaly   +2 more sources

Glucokinase-activating ureas

Bioorganic & Medicinal Chemistry Letters, 2005
The synthesis, SAR and biological evaluation of a series of ureas that activate glucokinase, a target for diabetes therapy as a result of its critical role in the regulation of whole-body glucose homeostasis, are described. Some of the urea-containing glucokinase activators lowered blood glucose levels in vivo following oral dosing to C57BL/6J mice.
Arlindo L, Castelhano, Hanqing, Dong, Matthew C T, Fyfe, Lisa S, Gardner, Yukari, Kamikozawa, Satomi, Kurabayashi, Masao, Nawano, Rikiya, Ohashi, Martin J, Procter, Li, Qiu, Chrystelle M, Rasamison, Karen L, Schofield, Vilas K, Shah, Kiichiro, Ueta, Geoffrey M, Williams, David, Witter, Kosuke, Yasuda   +16 more
openaire   +2 more sources

Role of ATP-glucokinase and polyphosphate glucokinase inStreptomyces aureofaciens

Folia Microbiologica, 1976
The activity of ATP-glucokinase and of polyphosphate glucokinase was examined during growth of the actinomycete Streptomyces aureofaciens 8425 under conditions of intense chlortetracycline (CTC) synthesis. ATP-glucokinase was active in the strain only during the logarithmic phase of culture growth; the activity of polyphosphate glucokinase appears only
Z, Hostálek, I, Tobek, M A, Bobyk, I S, Kulayev   +3 more
openaire   +2 more sources